PGR and invasive ductal breast carcinoma: The choice of breast cancer cell line for this work (MCF-7) was established from invasive ductal carcinoma (IDC) of a Caucasian patient and the cells are known to be estrogen (ER) and progesterone receptor (PgR)-positive.